Replication of hepatitis C virus in peripheral blood mononuclear cells in patients with chronic Hepatitis C treated with pegylated interferon alpha and ribavirin

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 67, Issue , 2013, Pages 186-191

  Inglot, Malgorzata ^a   Pawlowski, Tomasz ^a   Szymczak, Aleksandra ^a   Malyszczak, Krzysztof ^a   Zalewska, Malgorzata ^a   Radkowski, Marek ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Extrahepatic replication; HCV; Negative HCV RNA strand; PBMC; Pegylated interferon alpha

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEG IFN SA; PEG-IFN-SA; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD; DRUG COMBINATION; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; MONONUCLEAR CELL; RECURRENT DISEASE; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECURRENCE; RIBAVIRIN; RNA, VIRAL; YOUNG ADULT;

EID: 84883205346     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1038785     Document Type: Article

References (24)

1. Berg T., Sarrazin C., Herrmann E., Hinrichsen H., Gerlach T., Zachoval R., Wiedenmann B., Hopf U., Zeuzem S.: Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology, 2003;37:600-609
2. Cribier B., Uhl G., Schmitt C., Doffoël M., Vetter D., Kirn A., Stoll-Keller F.: Follow-up of hepatitis C virus RNA in peripheral blood mononuclear cells during interferon therapy. Arch. Virol., 1999;144:355-364
3. de Felipe B., Leal M., Soriano-Sarabia N., Gutiérrez A., López-Cortés L., Molina-Pinelo S., Vallejo A.: HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse. J. Viral Hepat., 2009;16:21-27
4. Di Liberto G., Roque-Afonso A. M., Kara R., Ducoulombier D., Fallot G., Samuel D., Feray C.: Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology, 2006;131:76-84
5. Ferri C., Monti M., La Civita L., Longombardo G., Greco F., Pasero G., Gentilini P., Bombardieri S., Zignego A. L.: Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood, 1993;82:3701-3704
6. Fried M. W., Shiffman M. L., Reddy K. R., Smith C., Marinos G., Goncales F. L. Jr., Häussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., Yu J.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med., 2002;347:975-982
7. Gong G. Z., Lai L. Y., Jiang Y. F., He Y., Su X. S.: HCV replication in PBMC and its influence on interferon therapy. World J. Gastroenterol., 2003;9:291-294
8. Januszkiewicz-Lewandowska D., Wysocki J., Pernak M., Nowicka K., Zawada M., Rembowska J., Lewandowski K., Mańkowski P., Nowak J.: Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy. Jpn. J. Infect. Dis., 2007;60:29-32
9. Lanford R. E., Chavez D., Chisari F. V., Sureau C.: Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J. Virol., 1995;69:8079-8083
10. Laskus T., Operskalski E. A., Radkowski M., Wilkinson J., Mack W. J., de Giacomo M., Al-Harthi L., Chen Z., Xu J., Kovacs A.: Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/ HIV-infected women. J. Infect. Dis., 2007;195:124-133
11. Laskus T., Radkowski M., Wang L. F., Vargas H., Rakela J.: Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology, 1998;28:1398-1401
12. Lerat H., Berby F., Trabaud M. A., Vidalin O., Major M., Trépo C., Inchauspé G.: Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J. Clin. Invest., 1996;97:845-851
13. Majda-Stanisławska E., Bednarek M., Jóźwiak B., Sidorkiewicz M., Piekarska A., Kuydowicz J.: Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C. Acta Gastroenterol. Belg., 2006;69:187-190
14. Manns M. P., McHutchison J. G., Gordon S. C., Rustgi V. K., Shiffman M., Reindollar R., Goodman Z. D., Koury K., Ling M., Albrecht J. K.: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet, 2001;358:958-965
15. Mohamad H. I., El-Bab H. K., Kamal A. M.: HCV RNA in serum and peripheral blood mononuclear cells after successful interferon therapy. Hepatogastroenterology, 2011;58:932-936
16. Moonka D. K., Henzel B. S., Gutekunst K., O'Brien C. B.: Quantitative assessment of hepatitis C virus RNA in peripheral blood mononuclear cells during therapy with interferon-α2a. J. Viral Hepat., 1998;5:27-33
17. Pugnale P., Herrmann E., Neumann A. U., Pawlotsky J. M., Schalm S. W., Ferrari C., Homburger Y., Zeuzem S., Negro F., DITTO-HCV Study Group: Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-α2a/ribavirin therapy. J. Hepatol., 2008;48:932-938
18. Radkowski M., Gallegos-Orozco J. F., Jabłońska J., Colby T. V., Walewska-Zielecka B., Kubicka J., Wilkinson J., Adair D., Rakela J., Laskus T.: Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology, 2005;41:106-114
19. Revie D., Salahuddin S. Z.: Human cell types important for hepatitis C virus replication in vivo and in vitro. Old assertions and current evidence. Virology J., 2011;8:346
20. Taylor M. W., Tsukahara T., Brodsky L., Schaley J., Sanda C., Stephens M. J., McClintick J. N., Edenberg H. J., Li L., Tavis J. E., Howell C., Belle S. H.: Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J. Virol., 2007;81:3391-3401
21. Xu D. Z., Xie Y., Li Z. Q.: Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C. Hepatobiliary Pancreat. Dis. Int., 2005;4:550-553
22. Yamaguchi Y., Hino K., Fujiwara D., Ren F., Katoh Y., Satoh Y., Okita K.: Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients. Dig. Dis. Sci., 2002;47:1611-1617
23. Zayed R. A., Rushdy E., Saleh D. A.: Detection of HCV RNA in the peripheral blood mononuclear cells of serum HCV RNA-negative Egyptian patients under interferon treatment. Am. J. Med. Sci., 2010;340:435-438
24. Zignego A. L., De Carli M., Monti M., Careccia G., La Villa G., Giannini C., D'Elios M. M., Del Prete G., Gentilini P.: Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J. Med. Virol., 1995;47:58-64